AV

ARCH Venture Management, LLC

13F
ARCH Venture Management, LLC
Last update 2025-05-15 9 Stocks (1 new)
Value $206.00 Mil Turnover 22 %
Countries:
ARCH Venture Management, LLC Top Holdings of 2025-03-31 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
BEAM
Beam Therapeutics Inc
4,540,132
88,668.8
0%
43.000
0%
4.510
+21.57%
-19.31%
2,012.1
Biotechnology
MAZE
Maze Therapeutics Inc
4,120,053
45,361.8
New Holding
22.000
+22.00%
9.410
+23.39%
0%
503.7
Biotechnology
RAPP
Rapport Therapeutics Inc
3,728,738
37,548.4
0%
18.210
0%
10.220
+41.31%
-32.13%
439.4
Biotechnology
ERAS
Erasca Inc
11,055,554
15,146.1
0%
7.340
0%
3.900
+19.01%
-42.63%
407.9
Biotechnology
VERV
Verve Therapeutics Inc
2,008,809
9,120.0
0%
4.420
0%
2.250
+193.37%
+100.00%
1,007.4
Biotechnology
GOSS
Gossamer Bio Inc
8,055,916
8,781.0
0%
4.260
0%
3.550
+31.72%
+37.08%
281.9
Biotechnology
UBX
Unity Biotechnology Inc
1,004,817
1,045.0
0%
0.510
0%
5.840
-70.41%
-70.00%
5.0
Biotechnology
QTTB
Q32 Bio Inc
320,482
532.0
0%
0.260
0%
2.630
-10.00%
-58.14%
17.6
Biotechnology
CERO
CERo Therapeutics Holdings Inc
1,105
16.1
-76.47%
0.010
-0.18%
0.400
-33.76%
-92.28%
4.8
Biotechnology
OMIC
Singular Genomics Systems Inc
0
0
Sold Out
0.000
-1.07%
0.000
-8.63%
+2.99%
50.8
Medical Devices & Instruments

ARCH Venture Management, LLC's Historical Top Holdings Breakdowns

ARCH Venture Management, LLC's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
MAZE
Maze Therapeutics Inc
2025-03-31
New Buy
New Buy
+22.00%
â—Ź
10.57 ($12.04) 15.95
$11.50
-4.49%
New holding
4,120,053
4,120,053
OMIC
Singular Genomics Systems Inc
2025-03-31
Sold Out
Sold Out
-1.07%
â—Ź
19.6 ($19.83) 20.01
$20.01
0.91%
Sold Out
0
-126,630
CERO
CERo Therapeutics Holdings Inc
2025-03-31
Reduce
Reduce
-0.18%
â—Ź
14.6 ($39.52) 122
$9.26
-76.57%
Reduce -76.47%
1,105
-71,834
BEAM
Beam Therapeutics Inc
2024-12-31
Reduce
Reduce
-2.77%
â—Ź
21.55 ($25.55) 30.35
$20.01
-21.68%
Reduce -6.09%
4,540,132
-294,521
CERO
CERo Therapeutics Holdings Inc
2024-12-31
Add
Add
+0.20%
â—Ź
101 ($233.59) 570.6
$9.26
-96.04%
Add 550.39%
4,697
7,949,265
BEAM
Beam Therapeutics Inc
2024-09-30
Reduce
Reduce
-5.36%
â—Ź
22.57 ($25.84) 33.14
$20.01
-22.56%
Reduce -11.18%
4,834,653
-608,386
BEAM
Beam Therapeutics Inc
2024-06-30
New Buy
New Buy
+47.94%
â—Ź
21.22 ($24.56) 32.66
$20.01
-18.53%
New holding
5,443,039
5,443,039
RAPP
Rapport Therapeutics Inc
2024-06-30
New Buy
New Buy
+32.60%
â—Ź
20.8 ($23.15) 26.19
$12.04
-47.99%
New holding
3,728,738
3,728,738
DNLI
Denali Therapeutics Inc
2024-06-30
Sold Out
Sold Out
-9.75%
â—Ź
14.96 ($19.2) 23.22
$14.69
-23.49%
Sold Out
0
-381,249
RVMD
Revolution Medicines Inc
2024-03-31
Sold Out
Sold Out
-56.72%
â—Ź
26.56 ($29.64) 33.55
$37.87
27.77%
Sold Out
0
-3,233,490

ARCH Venture Management, LLC Total Holding History ($B)

To

ARCH Venture Management, LLC's Asset Allocation

To

ARCH Venture Management, LLC Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

ARCH Venture Management, LLC's Hypothetical Growth since 2025-03-31

ARCH Venture Management, LLC's Yearly Returns

Year Portfolio % % Excess Gain %

ARCH Venture Management, LLC's Holdings Heat Map

Size field:

ARCH Venture Management, LLC's Holdings Bubble Chart

ARCH Venture Management, LLC News

  • 1

Discussions on ARCH Venture Management, LLC

No discussions yet.